Abstract
The conditions under which the sympathetic nervous system stimulates the secretion of glucagon have not yet been adequately defined. However, stressful situations, such as intensive physical exercise, birth, starvation, severe hypoglycemia, infection, extensive burns, rapid exsanguination, myocardial infarction and diabetes mellitus may be associated with heightened sympathetic activity. In these situations an increased supply of metabolic fuels in the form of endogenous glucose and free fatty acids would be advantageous and may be rapidly attained by direct neural stimulation of the liver and adipose tissue. This mobilization of nutrients is aided by an increased glucagon secretion in response to primary sympathetic nerve stimulation and to increased release of the catecholamines due to concomitant stimulation of the adrenal medulla.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aguilar-Parada, E., Eisentraut, A. M. and Unger, R. H. (1969): Effects of starvation on plasma pancreatic glucagon in normal man. Diabetes 18, 717–723.
Allison, S. P., Hinton, P. and Chamberlain, M. J. (1968): Intravenous glucose–tolerance, insulin and free-fatty-acid levels in burned patients. Lancet 2, 1113–1116.
Bencosme, S. A. (1959): Studies on the terminal autonomic nervous system with special reference to the pancreatic islets. Lab. Invest. 8, 629–646.
Bernard, C. (1849): Chiens rendus diabetiques. Compt. Rend. Soc. Biol. 1 60–64.
Bloom, S. R., Daniel, P. M., Johnston, D. I., Ogawa, O. and Pratt, O. E. (1973): Release of glucagon induced by stress. Quart. J. exp. Physiol. 58, 99–108.
Bloom, S. R., Edwards, A. V. and Vaughan, N. J. A. (1973): The role of the sympathetic innervation in the control of plasma glucagon concentration in the calf. J. Physiol. 233, 457–466.
Bloom, S. R., Edwards, A. V. and Vaughan, N. J. A. (1974): The role of the autonomic innervation in the control of glucagon release during hypoglycemia in the calf. J. Physiol. 236, 611–623.
Bloom, S. R., Vaughan, N. J. A. and Russell, R. C. G. (1974): Vagal control of glucagon release in man. Lancet 2, 546–549.
Bbttger, I., Schlein, E. M., Faloona, G. R., Knochel, J. P. and Unger, R. H. (1972): The effect of exercise on glucagon secretion. J. Clin. Endocrinol. Metab. 35, 117–125.
Brazeau, P. and Guillemin, R. (1974): Somatostatin: newcomer from the hypothalamus. N. Engl. J. Med. 290, 963–964.
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J. and Guillemin, R. (1973): Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179, 77–79.
Brown, M. and Vale, W. (1976): Effects of neurotensin and substance P on plasma insulin, glucagon and glucose levels. Endocrinology 98, 819–822.
Cannon, W. B., Mclver, M. A. and Bliss, S. W. (1924): Studies on the con–ditions of activity in endocrine glands. XIII. A sympathetic and adrenal mechanism for mobilising sugar in hypoglycemia. Am. J. Physiol. 69, 46–66.
Carraway, R. and Leeman, S. E. (1973): The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 248, 6854–6861.
Chang, M. M. and Leeman, S. E. (1970): Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance. P. J. Biol. Chem. 245, 4784–4790.
De Vane, G. W., Slier, T. M. and Yen, S. S. C. (1974): Acute suppression of insulin and glucose levels by synthetic somatostatin in normal human subjects. J. Clin. Endocrinol. Metab. 38, 913–915.
Edwards, A. V. (1972): The sensitivity of the hepatic glycogenolytic mechanism to stimulation of the splanchnic nerves. J. Physiol. 220, 315–334.
Edwards, A. V. (1972): The hyperglycemic response to stimulation of the hepatic sympathetic innervation in adrenalectomized cats and dogs. J. Physiol. 220, 697–710.
Edwards, A. V. and Silver, M. (1970): The glycogenolytic response to stimulation of the splanchnic nerves in adrenalectomized calves. J. Physiol. 211, 109–124.
Esterhuizen, A. C. and Howell, S. L. (1970): Ultrastructure of the A cells of cat islets of Langerhans following sympathetic stimulation of glucagon secretion. J. Cell. Biol. 46, 593–598.
Esterhuizen, A. C., Spriggs, T. L. B. and Lever, J. D. (1968): Nature of islet cell innervation in the cat pancreas. Diabetes 17, 33–36.
Ezdinli, E. Z., Javid, R., Owens, G. and Sokal, J. E. (1968): Effect of high spinal cord section on epinephrine hyperglycemia. Am. J. Physiol. 214, 1019–1024.
Ezdinli, E. Z. and Sokal, J. E. (1966): Comparison of glucagon and epinephrine effects in the dog. Endocrinology 713, 47–54.
Felig, P., Wahren, J., Hendler, R. and Ahlborg, G. (1972): Plasma glucagon levels in exercising man. N. Engl. J. Med. 287, 184–185.
Frohman, L. A. and Bernardis, L. L. (1971): Effect of hypothalamic stimulation on plasma glucose, insulin and glucagon levels. Am. J. Physiol. 221, 1596–1603.
Frohman, L. A., Ezdinli, E. Z. and Javid, R. (1967): Effect of vagotomy and vagal stimulation on insulin secretion. Diabetes 155, 443–448.
Gerich, J. E., Lorenzi, M., Schneider, V., Karam, J. H., Rivier, J., Guillemin, R. and Forsham, P. H. (1974): Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. N. Engl. J. Med. 291, 544–547.
Girard, J., Bal, D. and Assan, R. (1972): Glucagon secretion during the early postnatal period in the rat. Horm. Metab. Res. 4, 168–170.
Goldfine, I. D., Abraira, C., Gruenewald, D. and Goldstein, M. S. (1970): Plasma insulin levels during imaginary food ingestion under hypnosis. Proc. Soc. Exp. Biol. Med. 133, 274–276.
Hinton, P., Allison, S. P., Littlejohn, S. and Lloyd, J. (1971): Insulin and glucose to reduce catabolic response to injury in burned patients. Lancet 1, 767–769.
Iversen, J. (1973): Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas. J. Clin. Invest. 52, 2102–2116. —
Iversen, J. (1973): Effect of acetylcholine on the secretion of glucagon and insulin from the isolated, perfused canine pancreas. Diabetes 22, 381– 387.
Iversen, J. (1974); Inhibition of pancreatic glucagon release by somatostatin in vitro. Scand. J. Clin. Lab. Invest. 33, 125–129.
Johnson, D. G., Ensinck, J. W., Koerker, d., Palmer, J. and Goodner, C. J. (1975): Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ. Endocrinology 10, 370–374.
Johnston, D. I. and Bloom, S. R. (1973): Plasma glucagon levels in the term human infant and effect of hypoxia. Arch. Dis. Childh. 48, 451–545.
Kaneto, A., Kajinuma, H., Hayashi, M. and Kosaka, K. (1973): Effect of splanchnic nerve stimulation on glucagon and insulin secretion. Endocrinologia Japon. 20, 609–617.
Kaneto, A., Kajinuma, H. and Kosaka, K. (1975): Effect of splanchnic nerve stimulation on glucagon and insulin output in the dog. Endocrinology 10, 143–150.
Kaneto, A., Kajinuma, H., Kosaka, K. and Nakao, K. (1968): Stimulation of insulin secretion by parasympathomimetic agents. Endocrinology 83, 651–658.
Kaneto, A. and Kosaka, K. (1974): Stimulation of glucagon and insulin secretion by acetylcholine infused intrapancreatically. Endocrinology 915, 676–681.
Kaneto, A., Kosaka, K. and Nakao, K. (1967): Effects of stimulation of the vagus nerve on insulin secretion. Endocrinology 80, 530–536.
Kaneto, A., Miki, E. and Kosaka, K. (1974): Effects of vagal stimulation on glucagon and insulin secretion. Endocrinology 95, 1005–1010.
Kaneto, A., Miki, E. and Kosaka, K. (1975): Effect of beta, and beta2 adrenoreceptor stimulants infused intrapancreatically on glucagon and insulin secretion. Endocrinology 97, 1166–1173.
Kobayashi, S. and Fujita, T. (1969): Fine structure of mammalian and avian pancreatic islets with special reference to D cells and nervous elements. Z. Zellforsch. Mikrosk. Anat. 100, 340–363.
Koerker, D. J., Ruch, W., Chideckel, E., Palmer, J., Goodner, C. J., Ensinck, J. and Gale, C. C. (1974): Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 184, 482–484.
Langerhans, P. (1869): Beitrage zur mikroskopischen Anatomie der Bauch– speicheldrc/se. Thesis, Friedrich-Wilhelms-Universitat, Berlin, p. 1.
Laniado, S., Segal, P. and Esrig, B. (1973): The role of glucagon hyper–secretion in the pathogenesis of hyperglycemia following acute myocardial infarction. Circulation 48, 797–800.
Lawrence, A. M. (1966): Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia and glucose administration. Proc. Natl. Acad. Sci. USA 55, 316–320.
Leblanc, H., Anderson, J. R., Sigel, M. B. and Yen, S. S. C. (1975): Inhibitory action of somatostatin on pancreatic a and 6 cell function. J. Clin. Endocrinol. Metab. 40, 568–572.
Leclercq-Meyer, V., Brisson, G. R. and Malaisse, W. J. (1971): Effect of adrenaline and glucose on release of glucagon and insulin in vitro. Nature (Lond.) 231, 248–249.
Leffebvre, P. J., Luyckx, A. S. and Federspil, G. (1972): Muscular exercise and pancreatic function in rats. Israel J. Med. Sci. 8, 390–393.
Legg, P. G. (1967): The fine structure and innervation of the beta and delta cells in the islets of Langerhans of the cat. Z. Zellforsch. Mikrosk. Anat. 80, 307–321.
Lindsey, C. A., Faloona, G. R. and Unger, R. H. (1975): Plasma glucagon levels during rapid exsanguination with and without adrenergic blockade. Diabetes 24, 313–316.
Loubatieres, A., Mariani, M. M., Sorel, G. and Savi, L. (1971): The action of B–adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of B-receptor. Diabetologia 7., 127–132.
Luyckx, A. S. and Lefebvre, P. J. (1974): Mechanisms involved in the exercise–induced increase in glucagon secretion in rats. Diabetes 23, 81–93.
Marliss, E. B., Girardier, L., Seydoux, J., Wollheim, C. B., Kanazawa, Y., Orci, L., Renold, A. E. and Porte, D. Jr. (1973): Glucagon release induced by pancreatic nerve stimulation in the dog. J. Clin. Invest. 52, 1246–1259.
Mortimer, C. H., Carr, D., Lind, T., Bloom, S. R., Mallinson, C. N., Schally, A. V., Tunbridge, W. M. G., Yeomans, L., Coy, D. H., Kastin, A., Besser, G. M. and Hall, R. (1974): Effects of growth hormone release- inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet 1, 697–701.
Muller, W. A., Faloona, G. R., Aguilar-Parada, E. and Unger, R. H. (1970): Abnormal alpha–cell function in diabetes. N. Engl. J. Med. 283, 109–115.
Munger, B. L. (1972): The histology, cytochemistry and ultrastructure of pancreatic islet A-cells. In: Glucagon: Molecular Physiology, Clinical and Therapeutic Implications. P. J. Lefebvre and R. H. Unger, Eds. Pergamon Press, Oxford and New York, pp. 7–25.
Parra-Covarrubias, A., Rivera-Rodriguez, I. and Lamaraz–Ugalde, A. (1971): Cephalic phase of insulin secretion in obese adolescents. Diabetes 800–802.
Porte, D. Jr. (1967): A receptor mechanism for the inhibition of insulin release by epinephrine in man. J. Clin. Invest. 46,, 86–94.
Renold, A. E. (1971): The beta cell and its reponses. Diabetes 21, (Suppl. 2), 619–631.
Rocha, D. M., Santeusanio, F., Faloona, G. R. and Unger, R. H. (1973): Abnormal pancreatic alpha-cell function in bacterial infections. N. Engl. J. Med. 288, 700–703.
Rosenberg, F. J. and Distefano, V. (1962): A central nervous system component of epinephrine hyperglycemia. Am. J. Physiol. 203, 782–788.
Sakata, K., Hayano, S. and Sloviter, H. A. (1963): Effect on blood glucose concentration of changes in availability of glucose to the brain. Am. J. Physiol. 204, 1127–1132.
Sakurai, H., Dobbs, R. and Unger, R. H. (1974): Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs. J. Clin. Invest. 54, 1395–1402.
Sergeyeva, M. A. (1940): Microscopic changes in the islands of Langerhans by sympathetic and parasympathetic stimulation in the cat. Anat. Rec. 77, 297–317.
Shimazu, T. and Amakawa, A. (1968): Regulation of glycogen metabolism in liver by the autonomic nervous system. II. Neural control of glycogenolytic enzymes. Biochim. Biophys. Acta. 165, 335–348.
Shimazu, T. and Amakawa, A. (1968): Regulation of glycogen metabolism in liver by the autonomic nervous system. III. Differential effects of sympathetic nerve stimulation and of catecholamines on liver phosphorylase. Biochim. Biophys. Acta. 165, 349–356.
Stahl, M. (1963): Electronenmikroskopische Untersuchungen uber die vegetative Innervation der Bauchspeicheldruse. Z. Mikrosk. Anat. Forsch. 70, 62–102.
Tyler, J. M. and Kajinuma, H. (1972): Influence of beta–adrenergic and cholinergic agents in vivo on pancreatic glucagon and insulin secretion. Diabetes 21 (Suppl. 1), 332.
Tyler, J. M., Mialhe, P. and Kajinuma, H. (1972): Stimulation of pancreatic glucagon secretion by norepinephrine in vivo. Excerpta Medica No. 256,
Unger, R. H. (1971): Glucagon and the insulin: glucagon ratio in diabetes and other catabolic illness. Diabetes 20, 834–838.
Unger, R. H., Aguilar-Parada, E., Muller, W. A. and Eisentraut, A. M. (1970): Studies on pancreatic alpha cell function in normal and diabetic subjects. J. Clin. Invest. 49, 837–848.
Unger, R. H., Eisentraut, A. M., McCall, M. S. and Madison, L. L. (1962): Measurements of endogenous glucagon in plasma and the influence of blood glucose concentration upon its secretion. J. Clin. Invest. 41, 682–689.
Vendsalu, A. (1960): Studies on adrenaline and noradrenaline in human plasma. Acta Physiol. Scand. 49 (Suppl. 173), 1–123.
Watari, N. (1968): Fine structure of nervous elements in the pancreas of some vetebrates. Z. Zellforsch. Mikrosk. Anat. 85, 291–314.
Weir, G. C., Knowlton, S. D. and Martin, D. B. (1974): Somatostatin inhibition of epinephrine–induced glucagon secretion. Endocrinology 95, 1744– 1746.
Winborn, W. B. (1963): Light and electron microscopy of the islets of Langerhans of the Saimiri monkey pancreas. Anat. Rec. 147, 65–93.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag New York Inc.
About this paper
Cite this paper
Kaneto, A. (1977). The Role of the Autonomic Nervous System in Glucagon Secretion. In: Foà, P.P., Bajaj, J.S., Foà, N.L. (eds) GLUCAGON: Its Role in Physiology and Clinical Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-6366-1_20
Download citation
DOI: https://doi.org/10.1007/978-1-4612-6366-1_20
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-6368-5
Online ISBN: 978-1-4612-6366-1
eBook Packages: Springer Book Archive